We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement
Analytical Cannabis Logo
×

Boyne Capital Has Acquired Marijuana Packaging

Original story from Boyne Capital

Published: Sep 28, 2021   

Complete the form below and we will email you a PDF version of "Boyne Capital Has Acquired Marijuana Packaging"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Analytical Cannabis?

Analytical Cannabis Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Boyne Capital Has Acquired Marijuana Packaging

Boyne Capital Partners is pleased to announce that its portfolio company A&A Global Imports (Marijuana Packaging) has acquired Aphecal Enterprises, a leading supplier of packaging materials and ancillary products to the high-growth medical and recreational cannabis industry. 

Since 2013, the Company has provided a one-stop-shop for its customers, offering approximately 2,500 products, including packaging products (such as glass jars, pop top bottles, vials, tubes, and retail exit bags) and other ancillary goods. As part of the transaction, A&A also acquired the intellectual property related to the manufacture of Squeezetops®, a popular brand of regulatory compliant, child-resistant containers. In addition to its flagship website, www.420packaging.com, the Company operates the highly trafficked www.smokecones.com and www.humiditypacks.com which focus on various cannabis-related ancillaries.

Boyne Managing Partner and CEO, Derek McDowell, said, “A&A is committed to pursuing strategic acquisitions where it can leverage its robust supply chain and marketing expertise to drive growth. Aphecal is a prime example of an opportunity where A&A can bring more products to more customers at market leading pricing. We look forward to pursuing more great investments with the A&A team.” 

David Aryan, A&A founder and CEO said, “We’re very excited to have closed on this acquisition. Aphecal will broaden our reach while allowing us to enhance the product portfolio on Aphecal’s already impressive e-commerce platform. At the same time, the IP we’ve gained will fit perfectly within our portfolio of exclusive products. The Boyne team and the M&A expertise they’ve brought to A&A has proven a great asset.”

A&A is a platform investment in BCM Fund II. Boyne Capital is dedicated to investing in the lower middle market sector, specifically companies with revenues of less than $100 million and with EBITDA of $3 million to $15 million.

This article has been republished from material provided by Boyne Capital. Note: material may have been edited for length and content. For further information, please contact the cited source.

 

Stay connected with the latest news in cannabis extraction, science and testing

Get the latest news with the FREE weekly Analytical Cannabis newsletter

 
Advertisement